These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3698034)

  • 21. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
    Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
    Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas.
    Chen C; Zhu YB; Shen Y; Zhu YH; Zhang XG; Huang JA
    J Immunother; 2012 May; 35(4):354-8. PubMed ID: 22495393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of occult tumor cells in resected lymph nodes of patients with stage I carcinoma and its clinico-pathological significance].
    Chen Z; Lu X; Huang R
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):69-71. PubMed ID: 10743062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and prognostic relation of cathepsin D in non-small cell lung cancer tissues and lymph nodes].
    Wang Z; Zhao X
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Mar; 21(3):164-6. PubMed ID: 11263354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of lymph nodes dissection of lung cancer treatment].
    Konaka C; Kato H; Sato M; Hiyoshi T; Saito H
    Kyobu Geka; 1994 Jan; 47(1):45-8. PubMed ID: 8277633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.
    Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Ohno Y; Suzuki N; Inoue M; Soma G; Nagasue N
    Anticancer Res; 2005; 25(1B):463-70. PubMed ID: 15816613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer.
    Nakagawa T; Okumura N; Kokado Y; Miyoshi K; Matsuoka T; Kameyama K
    Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):474-8. PubMed ID: 17669909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
    J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.
    Lee JG; Cho BC; Bae MK; Lee CY; Park IK; Kim DJ; Ahn SV; Chung KY
    Lung Cancer; 2009 Jan; 63(1):106-10. PubMed ID: 18513823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modality of failure following resection of stage I and stage II non-small cell lung cancer.
    Ramacciato G; Paolini A; Volpino P; Aurello P; Balesh AM; D'Andrea N; Del Grande E; Passaro U; Tosato F; Fegiz G
    Int Surg; 1995; 80(2):156-61. PubMed ID: 8530234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunomorphologic responses of regional lymph nodes and prognosis in patients with stage Ia pulmonary adenocarcinoma].
    Takakura H; Hirohasi S; Shimosato Y; Kodama T; Kameya T; Naruke T; Suemasu K
    Gan No Rinsho; 1983 Jun; 29(7):777-84. PubMed ID: 6876444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer.
    Ohno S; Ohno Y; Suzuki N; Kamei T; Koike K; Inagawa H; Kohchi C; Soma G; Inoue M
    Anticancer Res; 2004; 24(5C):3335-42. PubMed ID: 15515429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.
    Ohta Y; Oda M; Wu J; Tsunezuka Y; Hiroshi M; Nonomura A; Watanabe G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):900-6. PubMed ID: 11689794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis.
    Wisnivesky JP; Henschke C; McGinn T; Iannuzzi MC
    Lung Cancer; 2005 Aug; 49(2):181-6. PubMed ID: 16022911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.